Figure 1.
Progression-free survival curves for metastatic esophageal cancer patients treated with nanoparticle albumin-bound paclitaxel plus cisplatin (n = 33).
Progression-free survival curves for metastatic esophageal cancer patients treated with nanoparticle albumin-bound paclitaxel plus cisplatin (n = 33).